We investigated the protective effects of propofol in the HK2 cell line of human kidney proximal tubular cells against hydrogen peroxide (H 2 O 2 )induced oxidative stress. 
Introduction
Renal ischemia/reperfusion (I/R) damage can occur in many clinical situations such as during renovascular surgery, clamping of the aorta, shock, trauma, and renal transplantation. Acute tubular necrosis (ATN) and renal failure related to I/R are the main reasons for morbidity and mortality in hospitalized patients [1] . ATN arises as a result of damage created by free oxygen radicals that are formed during I/R [2] . Oxygen free radicals, such as superoxide anion, hydroxyl radicals and hydrogen peroxide (H 2 O 2 ) are key mediators of renal reper fusion injury [3] . These reactive oxygen species cause lipid peroxidation of the renal cell membrane, which results in intracellular calcium overload and subsequent necrotic cell death [4, 5] .
Following renal transplantation, exposure of the graft to variable levels of I/R damage delays graft function, and can even cause graft loss [6] . Hence, approaches that prevent I/R damage should promote graft functions and enhance graft lifetime. When any manipulation that involves a risk of renal ischemic damage is planned, it would be prudent to have prophylactic treatments or anesthetic techniques in place in order to avoid I/ R damage.
Propofol (2, 6diisopropylphenol), a highly lipidsoluble anesthetic, is widely used for the induction and maintenance of general anesthesia. Propofol ameliorates I/R injury in several organs, including the heart [7] , lungs [8] , brain [9] , liver [10] , and testicles [11] . Some reports have described a protective effect of propofol against oxidative stress in rats at the nephrocyte [12] and wholeanimal levels [13] . However, there have been few reports on the effects of propofol on oxidative stress in human kidney cells.
In this study, we used the HK2 immortalized human proximal tubular cell line as a culture model, because proximal tubular cells are known to be the cell type most susceptible to ischemia in the kidney [14] . Moreover, HK2 cells have been used to study renal physiology and pathophysiology in vitro [15] . We hypothesized that propofol would protect human kidney cells against oxidantmediated damage. To test this hypothesis, we injured HK2 cells with H 2 O 2 and assessed cell death by measuring lactate dehydrogenase (LDH) release, counting viable cells, and performing flow cytometry on fluorescein isothiocyanate (FITC)labeled Annexin V/propidium iodide (PI) doublestained cells. 
Materials and Methods

Culture of HK-2 human renal proximal tubular cells
Measurement of cell death and cell viability
Whereas LDH normally localized to the cytoplasm in HK2 and most other cell types, its release in response to cell damage is a widely used indicator of incipient cell death. To quantify cell death, we measured LDH enzymatic activity in the collected medium using the spectrophotometric CytoTox 96 Ⓡ Non
Radioactive Cytotoxicity Assay (Promega, Madison, WI, USA), and then calculated the percentage of LDH release. The percentage of LDH release was calculated as (LDH) test / (LDH) total × 100, where (LDH) test is the measured LDH level in the experimental medium and (LDH) total is the total cellular LDH level per well measured after killing all cells by addition of the lysis solution (1% Triton X100) provided as part of the kit. Cell viability was measured using the trypan blue dye exclusion method. After treatment protocols were performed, cells were harvested and stained with 0.4% trypan blue dye for 5 minutes. The number of viable cells and total cells were counted using a hemocytometer.
The number of remaining nonviable cells was expressed as a percentage of the total number of cells.
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Annexin V-FITC/PI double-staining assay
Cell death was further analyzed by double staining cells with FITClabeled Annexin V and PI using the Annexin VFITC apoptosis detection kit (BD Biosciences, San Jose, CA, USA). Both floating and adherent cells were collected and plated onto a 12well plate at 1 × 10 6 cells/well. Cells were washed with phosphate buffered saline (PBS) and collected by trypsinization. After centrifugation at 400 × g for 5 minutes at 4 o C, pelleted cells were washed twice with cold PBS and then resuspended in Annexin V binding buffer. A total of 100 μl of cell suspension was transferred to test tubes, to which 5 μl of FITClabeled Annexin V and 5 μl of PI were added. The cells were gently vortexed and incubated for 15 minutes at room temperature in the dark. After adding 200 μl of binding buffer to each tube, the cells were analyzed by flow cytometry using the FACSCalibur system (BD Biosciences, San Jose, CA, USA). Annexin VFITC and PI emissions were detected in the FL 1 and FL 2 channels using 525 and 575 nm emission filters respectively. The Annexin VFITCnegative/PInegative population was considered to include all normal healthy cells. Annexin VFITCpositive/PI negative cells were regarded as a measure of early apoptosis. Annexin VFITCpositive/PIpositive population was considered to represent late apoptotic or necrotic cells, and Annexin VFITC negative/PIpositive cells were considered to include necrotic cells [16] . The percentage distributions of normal, early apo ptotic, late apoptotic, and necrotic cells were calculated using ModFitLT V3.0 software (BD Biosciences, San Jose, CA, USA).
Statistical analysis
Statistical analyses were performed using the SigmaStat program (version 3.10; Systat software, Chicago, IL, USA). Multiple groups were compared using oneway analysis of variance (ANOVA) or KruskalWallis oneway ANOVA on Ranks followed by pairwise multiple comparisons using a Tukey post hoc test as appropriate. In all comparisons, a P value less than 0.05 was considered to indicate a statistically significant difference. Data are presented as mean ± SD unless stated otherwise.
Results
Effect of propofol on LDH release
Treatment of HK2 cells for 4 hours by exposure to concen trations of 3 mM, 5 mM, or 8 mM H 2 O 2 or lysis solution (control group) increased the percentage of LDH release by 19.0 ± 2.2%, 22.4 ± 8.8%, 41.2 ± 6.5%, and 100.0 ± 7.4%, respectively (data not shown). We chose to use 8 mM H 2 O 2 in subsequent experiments as it induced an appropriate level of oxidative challenge. As shown in Fig. 1 , propofol treatment significantly decreased the amount of LDH released at 8 mM H 2 O 2 . Compared with a rate of LDH release of 45.1 ± 4.2% (n = 8) without propofol pretreatment, the rate of LDH release after pretreatment with 10 μM propofol was 38.1 ± 5.6%, (n = 8, P < 0.05), pretreatment with 25 μM propofol caused LDH release at a rate of 33.5 ± 6.3% (n = 8, P < 0.05), and pretreatment with 50 μM propofol caused LDH release at a rate of 26.2 ± 3.8% (n = 8, P < 0.05).
The rate of LDH release after pretreatment with 50 μM propofol was significantly different from that following pre treatment with either 10 μM or 25 μM of propofol (P < 0.05) and there was no significant difference between rates of LDH release after pretreatment with 10 μM propofol and pretreatment with 25 μM propofol (Fig. 1) . Fig. 2 ). The percentage increase in cell viability after pretreatment with 50 μM propofol was significantly different from that after pretreatment with either 10 μM or 25 μM propofol (P < 0.05) and there was no significant difference in cell viability following pretreatment with either 10 μM or 25 μM propofol (Fig. 2) .
Quantitation of H 2 O 2 -induced cell death with and without propofol pretreatment
Annexin VFITC binding analysis and PI staining were 
Discussion
In our present study, we evaluated whether propofol has a beneficial effect against renal I/R injury in human cells. The results indicated that propofol protects human proximal tubular cells against H 2 O 2 induced oxidative stress in vitro. Dealing with the detrimental effects of renal I/R injury that can result in acute renal failure, remains a serious clinical challenge [17] . Oxygen free radicals are key mediators of renal reperfusion injury [3] . During the postischemic reperfusion period, reactive oxygen species, such as the superoxide anion, hydroxyls radical, and H 2 O 2 , are generated. These reactive oxygen species cause lipid peroxidation of the renal cell membrane, resulting in intracellular calcium overload and subsequent necrotic cell death [4, 5] . In this study, we used H 2 O 2 mediated oxidative injury of HK2 cells as an in vitro model of reperfusion injury. We selected H 2 O 2 as the source of oxidative stress in this experi ment because it is a relatively stable oxidative stress radical that causes a variety of cell and tissue injuries. We used the HK2 human renal proximal tubular cell culture model because renal cells are susceptible to H 2 O 2 induced oxidative damage and renal cells with proximal tubular characteristics are much more susceptible to I/R injury than those with distal tubular characteristics [18] . Moreover, HK2 cells are used to study in vitro renal physiology and pathophysiology [15] . In our prelimi nary H 2 O 2 oxidative stress challenge tests using these cells, we found that a 4hour exposure to 5 mM H 2 O 2 resulted in an LDH release of 22.4 ± 8.8%, similar to the previously reported value of 25% after a 4hour challenge with 5 mM H 2 O 2 [19] .
Many reports have demonstrated that some anesthetic agents can attenuate oxidative stress in the kidney. Sevoflurane has antiinflammatory effects and antinecrotic effects in H 2 O 2 treated HK2 cells [19] . Propofol, which is chemically similar to a phenolbased free radical scavenger [20] , protects against oxidative stress in renal I/R injury [12] . Both of these studies involved measuring levels of serum creatinine and blood urea nitrogen and histological analysis of I/R injury in rat models of kidney damage. Histological findings from the two studies showed that propofol significantly reduced tissue necrosis. Another report, which suggested that propofol has antioxidant effects following kidney transplantation in humans, examined the impact of renal transplantation on oxidative stress and inflammation by measuring changes in the level of 8isoPGF 2α and 15ketodihydroPGF 2α , respectively [21] . The same study compared the antioxidant capacities of propofol and thiopentone during transplantation and after surgery. The levels of 8iso PGF 2α were significantly lower in the propofol group than in the thiopentone group [21] . However, propofol and thiopentone were used as induction agents in these experiments, not as maintenance agents. The plasma concentrations of propofol are reportedly 40-60 mM at the time of induction of anesthesia, and 10-25 mM during the maintenance of anesthesia [22] . To date, reports on the protective effects of propofol at the maintenance dose and studies on human renal cells are rare. Therefore we chose propofol concentrations of 10-50 mM, spanning the maintenancedose range, to determine the clinical relevance of the protective effects of propofol. Pretreatment with 50 mM propofol in a sample group was significantly different from 10 μM or 25 μM of propofol in another sample group in the experiments measuring LDH release and viable cell count, but not in flow cytometric analysis. There were many other causes for that difference, one of which was that more figures from future data might be needed for accurate flow cytometric study.
It is possible that the concentration of propofol that produces antioxidant effects may differ in a tissue and speciesspecific manner. Some authors have reported no beneficial effect of propofol in cardiac surgical patients when administrated at a conventional clinical concentration of 2-4 mg/ml (11-23 mM) compared with the volatile anesthetic sevoflurane [23] . In contrast, propofol, when given at 6-8 mg/ml (3546 mM) during myocardial ischemia and the early phase of reperfusion, attenuates freeradicalmediated and inflammatory com Vol. 63, No. 5, November 2012 Antioxidant effects of propofol ponents of myocardial reperfusion injury in patients undergoing elective coronary artery bypass graft surgery more effectively than the volatile anesthetic isoflurane [24] . These observations suggest that the potential cardioprotective effects of propofol in patients are dosedependent. Divergent effects of propofol have also been reported with respect to vascular endothelial cells [25] .
In conclusion, propofol attenuates renal oxidative injury in vitro, which has potential clinical implications. Thus, propofol may be a good anesthetic agent in surgeries that carry a risk of renal I/R injury, such as kidney transplantation. However, further in vivo and in vitro studies are needed to elucidate the protective mechanism involved and to establish the optimally protective concentration range of propofol in humans.
